Epigenetic role of miRNAs in normal and leukemic hematopoiesis

Epigenomics

Volumn 5, Issue 5, 2013, Pages 539-552

  Pagano, Francesca ^a   De Marinis, Elisabetta ^a   Grignani, Francesco ^b   Nervi, Clara ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

differentiation; epigenetics; hematopoiesis; leukemia; miRNA

Indexed keywords

DNA METHYLTRANSFERASE 1; MICRORNA; MICRORNA 124; MICRORNA 191; MICRORNA 200C; MICRORNA 214; MICRORNA 290; MICRORNA 29B; UNCLASSIFIED DRUG; CHROMATIN;

BIOGENESIS; CELL DIFFERENTIATION; CELL MATURATION; CHROMATIN; CPG ISLAND; DNA METHYLATION; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENETIC TRANSCRIPTION; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; LEUKEMIA; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; GENETICS; HEMATOPOIETIC STEM CELL; METABOLISM;

CELL DIFFERENTIATION; CHROMATIN; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; MICRORNAS;

EID: 84885016663     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.13.55     Document Type: Review

References (109)

1. Shih AH, Abdel-Wahab O, Patel JP, Levine RL. The role of mutations in epigenetic regulators in myeloid malignancies. Nat. Rev. Cancer 12(9), 599-612 (2012).
2. Fazi F, Rosa A, Fatica A et al. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 123(5), 819-831 (2005).
3. Fazi F, Nervi C. MicroRNA: basic mechanisms and transcriptional regulatory networks for cell fate determination. Cardiovasc. Res. 79(4), 553-561 (2008).
4. Sato F, Tsuchiya S, Meltzer SJ, Shimizu K. MicroRNAs and epigenetics. FEBS J. 278(10), 1598-1609 (2011).
5. Kunej T, Godnic I, Ferdin J, Horvat S, Dovc P, Calin GA. Epigenetic regulation of microRNAs in cancer: an integrated review of literature. Mutat. Res. 717(1-2), 77-84 (2011).
6. Rouhi A, Mager DL, Humphries RK, Kuchenbauer F. MiRNAs, epigenetics, and cancer. Mamm. Genome 19(7-8), 517-525 (2008).
7. Garzon R, Liu S, Fabbri M et al. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 113(25), 6411-6418 (2009).
8. Zardo G, Ciolfi A, Vian L et al. Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression. Blood 119(17), 4034-4046 (2012).
9. Cedar H, Bergman Y. Epigenetics of haematopoietic cell development. Nat. Rev. Immunol. 11(7), 478-488 (2011).
10. Zardo G, Cimino G, Nervi C. Epigenetic plasticity of chromatin in embryonic and hematopoietic stem/progenitor cells: therapeutic potential of cell reprogramming. Leukemia 22(8), 1503-1518 (2008).
11. Bryder D, Rossi DJ, Weissman IL. Hematopoietic stem cells: the paradigmatic tissue-specific stem cell. Am. J. Pathol. 169(2), 338-346 (2006).
12. Sashida G, Iwama A. Epigenetic regulation of hematopoiesis. Int. J. Hematol. 96(4), 405-412 (2012).
13. Calvanese V, Fernández AF, Urdinguio RG et al. A promoter DNA demethylation landscape of human hematopoietic differentiation. Nucleic Acids Res. 40(1), 116-131 (2012).
14. Franchini DM, Schmitz K-M, Petersen-Mahrt SK. 5-methylcytosine DNA demethylation: more than losing a methyl group. Annu. Rev. Genet. 46, 419-441 (2012).
15. Geiger H, de Haan G, Florian MC. The ageing haematopoietic stem cell compartment. Nat. Rev. Immunol. 13(5), 376-389 (2013).
16. Bocker MT, Hellwig I, Breiling A, Eckstein V, Ho AD, Lyko F. Genome-wide promoter DNA methylation dynamics of human hematopoietic progenitor cells during differentiation and aging. Blood 117(19), e182-e189 (2011).
17. Cui K, Zang C, Roh T-Y et al. Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell 4(1), 80-93 (2009).
18. Pietersen AM, van Lohuizen M. Stem cell regulation by polycomb repressors: postponing commitment. Curr. Opin. Cell Biol. 20(2), 201-207 (2008).
19. Cao R, Zhang Y. SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex. Mol. Cell 15(1), 57-67 (2004).
20. Viré E, Brenner C, Deplus R et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439(7078), 871-874 (2006).
21. Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell 150(1), 12-27 (2012).
22. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75(5), 843-854 (1993).
23. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 294(5543), 853-858 (2001).
24. Lau NC, Lim LP, Weinstein EG, Bartel DP. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294, 858-862 (2001).
25. Lee RC, Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 294(5543), 862-864 (2001).
26. Ambros V. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 113(6), 673-676 (2003).
27. Griffiths-Jones S. The microRNA Registry. Nucleic Acids Res. 32, D109-D111 (2004).
28. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genetics 9(2), 102-114 (2008).
29. Lewis BP, Shih I, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell 115(7), 787-798 (2003).
30. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120(1), 15-20 (2005).
31. Peters L, Meister G. Argonaute proteins: mediators of RNA silencing. Mol. Cell 26, 611-623 (2007).
32. Baskerville S, Bartel DP. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 11(3), 241-247 (2005).
33. Kim VN. MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol. Cell Biol. 6, 376-385 (2005).
34. Morlando M, Ballarino M, Gromak N, Pagano F, Bozzoni I, Proudfoot NJ. Primary microRNA transcripts are processed co-transcriptionally. Nat. Struct. Mol. Biol. 15(9), 902-909 (2008).
35. Ballarino M, Pagano F, Girardi E et al. Coupled RNA processing and transcription of intergenic primary micrornas coupled RNA processing and transcription of intergenic. Mol. Cell. Biol. 29(20), 5632- 5638 (2009).
36. Denli AM, Tops BB, Plasterk RH, Ketting RF, Hannon GJ. Processing of primary microRNAs by the microprocessor complex. Nature 432(7014), 231-235 (2004).
37. Gregory RI, Yan KP, Amuthan G et al. The microprocessor complex mediates the genesis of microRNAs. Nature 432(7014), 235-240 (2004).
38. Chendrimada TP, Gregory RI, Kumaraswamy E et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 436(7051), 740-744 (2005).
39. Alemdehy MF, Erkeland SJ. MicroRNAs: key players of normal and malignant myelopoiesis. Curr. Opin. Hematol. 19(4), 261-267 (2012).
40. Bissels U, Bosio A, Wagner W. MicroRNAs are shaping the hematopoietic landscape. Haematologica 97(2), 160-167 (2012).
41. Guo S, Lu J, Schlanger R et al. MicroRNA miR-125a controls hematopoietic stem cell number. Proc. Natl Acad. Sci. USA 107(32), 14229-14234 (2010).
42. Arrate MP, Vincent T, Odvody J, Kar R, Jones SN, Eischen CM. MicroRNA biogenesis is required for Myc-induced B-cell lymphoma development and survival. Cancer Res. 70(14), 6083-6092 (2010).
43. O'Carroll D, Mecklenbrauker I, Das PP et al. A Slicer-independent role for Argonaute 2 in hematopoiesis and the microRNA pathway. Genes Dev. 21(16), 1999-2004 (2007).
44. Georgantas RW, Hildreth R, Morisot S et al. microRNA expression and function: a circuit diagram of differentiation control. Proc. Natl Acad. Sci. USA 104(8), 2750-2755 (2007).
45. Petriv OI, Kuchenbauer F, Delaney AD et al. Comprehensive microRNA expression profiling of the hematopoietic hierarchy. 107(35), 15443-15448 (2010).
46. Rhyasen GW, Starczynowski DT. Deregulation of microRNAs in myelodysplastic syndrome. Leukemia 26(1), 13-22 (2012).
47. Gordon JE, Wong JJ, Rasko JE. MicroRNAs in myeloid malignancies. Br. J. Haematol. 162(2), 162-176 (2013).
48. Esteller M. Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum. Mol. Genet. 16, R50-59 (2007).
49. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat. Rev. Genetics 3(6), 415-428 (2002).
50. Weber B, Stresemann C, Brueckner B, Lyko F. Methylation of human microRNA genes in normal and neoplastic cells. Cell Cycle 6(9), 1001-1005 (2007).
51. Bernstein BE, Meissner A, Lander ES. The mammalian epigenome. Cell 128(4), 669-681 (2007).
52. Fazi F, Racanicchi S, Zardo G et al. Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ ETO oncoprotein. Cancer cell 12(5), 457- 466 (2007).
53. Meng F, Henson R, Wehbe-Janek H, Smith H, Ueno Y, Patel T. The microRNA let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes. J. Biol. Chem. 282(11), 8256-8264 (2007).
54. Li Y, Gao L, Luo X et al. Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway. Blood 121(3), 499-509 (2013).
55. Díaz-Beyá M, Navarro A, Ferrer G et al. Acute myeloid leukemia with translocation (8;16)(p11;p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene. Leukemia 27(3), 595-603 (2013).
56. Bueno MJ, Perez de Castro I, Gomez de Cedron M et al. Genetic and epigenetic silencing of MicroRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer cell 13(6), 496-506 (2008).
57. Chim CS, Wan TS, Wong KY, Fung TK, Drexler HG, Wong KF. Methylation of miR- 34a, miR-34b/c, miR-124-121 and miR-203 in Ph-negative myeloproliferative neoplasms. J. Transl. Med. 9(1), 197 (2011).
58. Chim CS, Wong KY, Leung CY et al. Epigenetic inactivation of the hsa-miR-203 in haematological malignancies. J. Cell. Mol. Med. 15(12), 2760-2767 (2011).
59. Liu S, Wu L-C, Pang J et al. Sp1/NFkappaB/ HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia. Cancer cell 17(4), 333-347 (2010).
60. Gao X-N, Lin J, Li Y-H et al. MicroRNA- 193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia. Oncogene 30(31), 3416-3428 (2011).
61. Pigazzi M, Manara E, Bresolin S et al. MicroRNA-34b promoter hypermethylation induces CREB overexpression and contributes to myeloid transformation. Haematologica 98(4), 602-610 (2013).
62. Dickstein J, Senyuk V, Premanand K et al. Methylation and silencing of miRNA-124 by EVI1 and self-renewal exhaustion of hematopoietic stem cells in murine myelodysplastic syndrome. Proc. Natl Acad. Sci. USA 107(21), 9783-9788 (2010).
63. Erdogan B, Bosompem A, Peng D et al. Methylation of promoters of microRNAs and their host genes in myelodysplastic syndromes. Leuk. Lymphoma doi:10.3109/104 28194.2013.790542 (2013) (Epub ahead of print
64. Agirre X, Vilas-Zornoza A, Jiménez-Velasco A et al. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia. Cancer Res. 69(10), 4443-4453 (2009).
65. Roman-Gomez J, Agirre X, Jiménez-Velasco A et al. Epigenetic regulation of microRNAs in acute lymphoblastic leukemia. J. Clin. Oncol. 27(8), 1316-1322 (2009).
66. Pospisil V, Vargova K, Kokavec J et al. Epigenetic silencing of the oncogenic miR- 17-92 cluster during PU.1-directed macrophage differentiation. EMBO J. 30(21), 4450-4464 (2011).
67. Duan Z, Person RE, Lee H-H et al. Epigenetic regulation of protein-coding and microRNA genes by the Gfi1-interacting tumor suppressor PRDM5. Mol. Cell. Biol. 27(19), 6889-6902 (2007).
68. Hock H, Hamblen MJ, Rooke HM, Schindler JW, Saleque S, Fujiwara Y. Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells. Nature 431(7011), 1002-1007 (2004).
69. Duan Z, Horwitz M. Targets of the transcriptional repressor oncoprotein Gfi-1. Proc. Natl Acad. Sci. USA 100(10), 5932- 5937 (2003).
70. Spivakov M, Fisher AG. Epigenetic signatures of stem-cell identity. Nat. Rev. Genetics 8(4), 263-271 (2007).
71. So AY, Jung JW, Lee S, Kim HS, Kang KS. DNA methyltransferase controls stem cell aging by regulating BMI1 and EZH2 through microRNAs. PloS One 6(5), e19503 (2011).
72. Benetti R, Gonzalo S, Jaco I et al. A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases. Nat. Struct. Mol. Biol. 15(3), 268-279 (2008).
73. Sinkkonen L, Hugenschmidt T, Berninger P et al. MicroRNAs control de novo DNA methylation through regulation of transcriptional repressors in mouse embryonic stem cells. Nat. Struct. Mol. Biol. 15(3), 259-267 (2008).
74. Ji H, Ehrlich LI, Seita J et al. Comprehensive methylome map of lineage commitment from haematopoietic progenitors. Nature 467(7313), 338-342 (2010).
75. Juan AH, Kumar RM, Marx JG, Young RA. Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Mol. Cell. 36(1), 61-74 (2009).
76. Shimono Y, Zabala M, Cho RW et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138(3), 592-603 (2009).
77. Oguro H, Yuan J, Tanaka S et al. Lethal myelofibrosis induced by Bmi1-deficient hematopoietic cells unveils a tumor suppressor function of the polycomb group genes. J. Exp. Med. 209(3), 445-454 (2012).
78. Kamminga LM, Bystrykh LV, de Boer A et al. The Polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion. Blood 107(5), 2170-2179 (2006).
79. Kent DG, Dykstra BJ, Cheyne J, Ma E, Eaves CJ. Steel factor coordinately regulates the molecular signature and biologic function of hematopoietic stem cells. Blood 112(3), 560-567 (2008).
80. Cantor AB, Orkin SH. Transcriptional regulation of erythropoiesis: an affair involving multiple partners. Oncogene 21(21), 3368-3376 (1992).
81. Rice KL, Hormaeche I, Licht JD. Epigenetic regulation of normal and malignant hematopoiesis. Oncogene 26(47), 6697-6714 (2007).
82. Chen C, Lodish HF. MicroRNAs as regulators of mammalian hematopoiesis. Semin. Immunol. 17(2), 155-165 (2005).
83. Nervi C, Fazi F. Oncoproteins, heterochromatin silencing and microRNAs. Epigenetics 3(1), 1-4 (2008).
84. Grigoryev SA, Bulynko YA, Popova EY. The end adjusts the means: heterochromatin remodelling during terminal cell differentiation. Chromosome Res. 14(1), 53-69 (2006).
85. Popova EY, Krauss SW, Short SA et al. Chromatin condensation in terminally differentiating mouse erythroblasts does not involve special architectural proteins but depends on histone deacetylation. Chromosome Res. 17(1), 47-64 (2009).
86. Zhang L, Flygare J, Wong P, Lim B, Lodish HF. miR-191 regulates mouse erythroblast enucleation by down-regulating Riok3 and Mxi1. Genes Dev. 25(2), 119-124 (2011).
87. Fabbri M, Croce CM, Calin GA. MicroRNAs in the ontogeny of leukemias and lymphomas. Leuk. Lymphoma 50(2), 160-170 (2009).
88. Fabbri M, Garzon R, Cimmino A et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl Sci. USA 104(40), 15805-15810 (2007).
89. Iorio M V, Piovan C, Croce CM. Interplay between microRNAs and the epigenetic machinery: an intricate network. Biochim. Biophys. Acta. 1799(10-12), 694-701 (2010).
90. Jacob F, Monod J. Genetic regulatory mechanisms in the synthesis of proteins. J. Mol. Biol. 3, 318-356 (1961).
91. Schmitz KM, Mayer C, Postepska A, Grummt I. Interaction of noncoding RNA with the rDNA promoter mediates recruitment of DNMT3b and silencing of rRNA genes. Genes Dev. 24(20), 2264-2269 (2010).
92. Goni JR, De la Cruz X, Orozco M. Triplex-forming oligonucleotide target sequences in the human genome. Nucleic Acids Res. 32(1), 354-360 (2004).
93. Belotserkovskii BP, De Silva E, Tornaletti S, Wang G, Vasquez KM, Hanawalt PC. A triplex-forming sequence from the human c-MYC promoter interferes with DNA transcription. J. Biol. Chem. 282(44), 32433-32441 (2007).
94. Weinmann L, Höck J, Ivacevic T et al. Importin 8 is a gene silencing factor that targets argonaute proteins to distinct mRNAs. Cell 136(3), 496-507 (2009).
95. Liao JY, Ma LM, Guo YH et al. Deep sequencing of human nuclear and cytoplasmic small RNAs reveals an unexpectedly complex subcellular distribution of miRNAs and tRNA 3́ trailers. PLoS One 5(5), e10563 (2010).
96. Zaratiegui M, Irvine DV, Martienssen RA. Noncoding RNAs and gene silencing. Cell 128(4), 763-776 (2007).
97. Han J, Kim D, Morris KV. Promoter-associated RNA is required for RNA-directed transcriptional gene silencing in human cells. Proc. Natl Acad. Sci. USA 104(30), 12422- 12427 (2007).
98. Ting AH, Schuebel KE, Herman JG, Baylin SB. Short dsRNA induces transcriptional gene silencing in human cancer cells in the absence of DNA methylation. Nat. Genet. 37(8), 906-910 (2005).
99. Kim DH, Villeneuve LM, Morris K V, Rossi JJ. Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells. Nat. Struct. Mol. Biol. 13(9), 793-797 (2006).
100. Weinberg MS, Villeneuve LM, Ehsani AL et al. The antisense strand of small interfering RNAs directs histone methylation and transcriptional gene silencing in human cells. RNA 12(2), 256-262 (2006).
101. Matzke M, Birchler J. RNAi-mediated pathways in the nucleus. Nat. Rev. Genetics 6(1), 24-35 (2005).
102. Benhamed M, Herbig U, Ye T, Dejean A, Bischof O. Senescence is an endogenous trigger for microRNA-directed transcriptional gene silencing in human cells. Nat. Cell Biol. 14(3), 266-275 (2012).
103. Kim DH, Sætrom P, Snøve O, Rossi JJ. MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc. Natl Acad. Sci. USA 105(42), 16230-16235 (2008).
104. Zardo G, Fazi F, Travaglini L, Nervi C. Dynamic and reversibility of heterochromatic gene silencing in human disease. Cell Res. 15(9), 679-690 (2005).
105. Baer C, Claus R, Plass C. Genome-wide epigenetic regulation of miRNAs in cancer. Cancer Res. 73(2), 473-477 (2013).
106. Duursma AM, Kedde M, Schrier M, le Sage C, Agami R. miR-148 targets human DNMT3b protein coding region. RNA 14(5), 872-877 (2008).
107. Zardo G, Ciolfi A, Vian L et al. Transcriptional targeting by microRNA-polycomb complexes: a novel route in cell fate determination. Cell Cycle 11(19), 3543-3549 (2012).
108. Garzon R, Croce CM. MicroRNAs in normal and malignant hematopoiesis. Curr. Opin. Hematol. 15(4), 19-21 (2008).
109. Hsu SD, Lin FM, Wu WY et al. miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res. 39, D163-D169 (2011).